Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
June 26, 2026
Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions
Tereza Růžičková, Michal Kaščák, Zuzana Chyra, et al.
Blood Cancer Journal
|
December 3, 2024
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
Zhongfei Tao, Zuzana Chyra, Jana Kotulová, et al.
Biomarker Research
|
July 2, 2025
Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential
Jana Kotulová, Klára Baďurová, Zuzana Chyra, et al.
Frontiers in Genetics
|
May 16, 2022
Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Pavel Hurník, Zuzana Chyra, Tereza Ševčíková, et al.
Frontiers in Oncology
|
April 14, 2025
BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview
Dominika Gedeonová, Claretta Bianchi, Jan Štembírek, et al.
Journal of Translational Medicine
|
March 16, 2023
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
Piotr Celichowski, Marcello Turi, Sandra Charvátová, et al.
Molecular Diagnosis & Therapy
|
March 30, 2026
The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance
Klára Baďurová, Veronika Kapustová, Jana Kotulová, et al.
Journal of Clinical Pathology
|
February 19, 2018
Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
Zuzana Chyra Kufova, Tereza Sevcikova, Jaroslav Januska, et al.
Frontiers in Oncology
|
January 8, 2024
Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins
Pavel Hurník, Jana Režnarová, Zuzana Chyra, et al.
Leukemia
|
May 5, 2022
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
Sophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
June 26, 2026
Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions
Tereza Růžičková, Michal Kaščák, Zuzana Chyra, et al.
Blood Cancer Journal
|
December 3, 2024
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
Zhongfei Tao, Zuzana Chyra, Jana Kotulová, et al.
Biomarker Research
|
July 2, 2025
Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential
Jana Kotulová, Klára Baďurová, Zuzana Chyra, et al.
Frontiers in Genetics
|
May 16, 2022
Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Pavel Hurník, Zuzana Chyra, Tereza Ševčíková, et al.
Frontiers in Oncology
|
April 14, 2025
BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview
Dominika Gedeonová, Claretta Bianchi, Jan Štembírek, et al.
Journal of Translational Medicine
|
March 16, 2023
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
Piotr Celichowski, Marcello Turi, Sandra Charvátová, et al.
Molecular Diagnosis & Therapy
|
March 30, 2026
The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance
Klára Baďurová, Veronika Kapustová, Jana Kotulová, et al.
Journal of Clinical Pathology
|
February 19, 2018
Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
Zuzana Chyra Kufova, Tereza Sevcikova, Jaroslav Januska, et al.
Frontiers in Oncology
|
January 8, 2024
Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins
Pavel Hurník, Jana Režnarová, Zuzana Chyra, et al.
Leukemia
|
May 5, 2022
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
Sophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Page
of 3